Wisconsin Administrative Code
Controlled Substances Board
Chapter CSB 2 - Additions To Schedules In SS. 961.14, 961.16, 961.18, 961.20 And 961.22, Stats
Appendix - Appendix
- Section CSB 2.01 - Addition of methaqualone to schedule II
- Section CSB 2.02 - Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III
- Section CSB 2.03 - Addition of fenfluramine to schedule IV
- Section CSB 2.04 - Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III
- Section CSB 2.05 - Addition of drotebanol to schedule I
- Section CSB 2.06 - Addition of pentazocine to schedule III
- Section CSB 2.07 - Transfer of hydrochloride form of etorphine from schedule I to schedule II
- Section CSB 2.08 - Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV
- Section CSB 2.09 - Additions to schedules IV and I
- Section CSB 2.10 - Addition of propiram to schedule I
- Section CSB 2.11 - Renumbering and addition to schedule IV of diethylpropion and phentermine
- Section CSB 2.13 - Addition of dextropropoxyphene to schedule IV
- Section CSB 2.14 - Addition of prazepam to schedule IV
- Section CSB 2.15 - Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV
- Section CSB 2.16 - Transfer of sufentanil from schedule I to schedule II
- Section CSB 2.17 - Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II
- Section CSB 2.18 - Addition of 3,4-methylenedioxymethamphetamine to schedule I
- Section CSB 2.19 - Additions, deletions and transfers to statutory schedules
- Section CSB 2.20 - Addition of beta-hydroxy-3-methylfentanyl to schedule I
- Section CSB 2.21 - Additions, deletions, corrections, transfers, and amendments to drug schedules
- Section CSB 2.22 - Additions to drug schedules
- Section CSB 2.23 - Additions and amendments to drug schedules
- Section CSB 2.24 - Addition of butorphanol to schedule IV
- Section CSB 2.25 - Addition of remifentanil to schedule II; transfer of dronabinol from schedule II to schedule III; addition of fenproporex, modafinil, sibutramine, zaleplon and zolpidem to schedule IV; spelling correction of carfentanil
- Section CSB 2.26 - Addition of dihydroetorphine to schedule II
- Section CSB 2.28 - Addition of dichloralphenazone to schedule IV
- Section CSB 2.29 - Transfer of buprenorphine from schedule V to schedule III
- Section CSB 2.30 - Addition of gamma-hydroxybutyric acid to schedule III
- Section CSB 2.31 - Addition of 2,5 dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) to schedule I
- Section CSB 2.32 - Addition of N- benzylpiperazine (BZP) to schedule I
- Section CSB 2.33 - Addition of alpha-methyltryptamine (AMT) to schedule I
- Section CSB 2.34 - Addition of 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT)
- Section CSB 2.35 - Addition of lisdexamfetamine to schedule II
- Section CSB 2.36 - Addition of tramadol to schedule IV
- Section CSB 2.37 - Rescheduling of hydrocodone combination products
- Section CSB 2.38 - Addition of suvorexant to schedule IV
- Section CSB 2.39 - Exclusion of naloxegol
- Section CSB 2.40 - Exclusion of [123I] ioflupan
- Section CSB 2.41 - Scheduling of beta-hydroxythiofentanyl and butyryl fentanyl
- Section CSB 2.42 - Scheduling of furanyl fentanyl
- Section CSB 2.43 - Addition of brivaracetam to schedule V
- Section CSB 2.44 - Addition of thiafentanil to schedule II
- Section CSB 2.45 - Addition of AB-FUBINACA and ADB-PINACA to schedule I
- Section CSB 2.46 - Addition of acetyl fentanyl to schedule I
- Section CSB 2.47 - Addition of AH-7921 to schedule I
- Section CSB 2.48 - Addition of eluxadoline to schedule IV
- Section CSB 2.49 - Addition of U-47700 to schedule I
- Section CSB 2.50 - Addition of AB-CHMINACA, AB-PINACA and THJ-2201 to schedule I
- Section CSB 2.51 - Addition of MAB-CHMINACA to schedule I
- Section CSB 2.52 - Addition of 4-MePPP and a-PBP to schedule I
- Section CSB 2.53 - Scheduling of acryl fentanyl
- Section CSB 2.54 - Addition of oral solutions containing dronabinol to schedule II
- Section CSB 2.55 - Addition of 5F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA to schedule I
- Section CSB 2.56 - Addition of 4-fluoroisobutyryl fentanyl to schedule I
- Section CSB 2.57 - Scheduling of cyclopropyl fentanyl
- Section CSB 2.58 - Exclusion of naldemedine
- Section CSB 2.59 - Addition of ortho-fluorofentanyl to schedule I
- Section CSB 2.60 - Addition of FUB-AMB to schedule I
- Section CSB 2.61 - Addition of MT-45 to schedule I
- Section CSB 2.62 - Addition of para-chloroisobutyryl fentanyl to schedule I
- Section CSB 2.63 - Addition of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA to schedule I
- Section CSB 2.64 - Addition of N-Ethylpentylone to schedule I
- Section CSB 2.65 - Addition of approved cannabidiol drugs to schedule V
- Section CSB 2.66 - Addition of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 to schedule I
- Section CSB 2.67 - Addition of Brexanolone and Solriamfetol to schedule IV
- Section CSB 2.68 - Addition of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP to schedule I
- Section CSB 2.69 - Addition of Noroxymorphone to schedule II
- Section CSB 2.70 - Scheduling 4F-MDMB-BINACA and MMB-FUBICA
- Section CSB 2.71 - Addition of lasmiditan to schedule V
- Section CSB 2.72 - Scheduling of isotonitazene and 1P-LSD
- Section CSB 2.73 - Addition of cenobamate to schedule V
- Section CSB 2.74 - Addition of Lemborexant to schedule IV
- Section CSB 2.75 - Exclusion of approved cannabidiol drugs from schedule I
- Section CSB 2.76 - Addition of norfentanyl to schedule II
- Section CSB 2.77 - Scheduling of flualprazolam
- Section CSB 2.78 - Addition of crotonyl fentanyl to schedule I
- Section CSB 2.79 - Addition of remimazolam to schedule IV
- Section CSB 2.80 - Scheduling of oliceridine
- Section CSB 2.81 - Addition of brorphine to schedule I
- Section CSB 2.82 - Addition of Serdexmethylphenidate to schedule IV
- Section CSB 2.83 - Addition of ten (10) fentanyl-related substances to schedule I
- Section CSB 2.84 - Addition of alfaxalone to schedule IV
- Section CSB 2.85 - Excluding 6-beta-naltrexol from schedule II
- Section CSB 2.86 - Addition of fospropofol to schedule IV
- Section CSB 2.87 - Addition of embutramide to schedule III
- Section CSB 2.88 - Addition of lacosamide to schedule V
- Section CSB 2.89 - Addition of perampanel to schedule III
- Section CSB 2.90 - Transfer of 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP, from Schedule I to schedule II
- Section CSB 2.91 - Addition of 4,4'-Dimethylaminorex to schedule I
- Section CSB 2.92 - Addition of thirty-eight (38) Anabolic Steroids to schedule III
- Section CSB 2.93 - Addition of Daridorexant to schedule IV
- Section CSB 2.94 - Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I
- Section CSB 2.95 - Addition of Ganaxolone to schedule V
- Section CSB 2.96 - Addition of Amineptine to schedule I
- Section CSB 2.97 - Addition of Zipeprol to schedule I
- Section CSB 2.98 - xcluding [[18]F] FP-CIT from schedule II
- Section CSB 2.99 - Addition of Mesocarb to schedule I
Current through February 26, 2024
This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss. CSB 2.01 to 2.99.
Disclaimer: These regulations may not be the most recent version. Wisconsin may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
